Triple
T14177367
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Khosla Ventures |
E351366
|
entity |
| Predicate | portfolioCompany |
P43497
|
FINISHED |
| Object |
Guardant Health
Guardant Health is a precision oncology company specializing in blood-based liquid biopsy tests to detect, monitor, and guide treatment of cancer.
|
E1084550
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Guardant Health | Statement: [Khosla Ventures, portfolioCompany, Guardant Health]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Guardant Health Context triple: [Khosla Ventures, portfolioCompany, Guardant Health]
-
A.
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals is a leading American biotechnology company known for developing innovative antibody-based therapies for serious diseases, including eye disorders, cancer, and inflammatory conditions.
-
B.
Ariad Pharmaceuticals
Ariad Pharmaceuticals was a biotechnology company focused on developing targeted therapies for cancer and other serious diseases.
-
C.
Seagen
Seagen is a biotechnology company specializing in the development of antibody-drug conjugate (ADC) therapies for cancer treatment.
-
D.
Genocea Biosciences
Genocea Biosciences is a biotechnology company that develops T cell–targeted vaccines and immunotherapies using a proprietary antigen discovery platform.
-
E.
BioNTech
BioNTech is a German biotechnology company best known for developing one of the first mRNA-based COVID-19 vaccines in partnership with Pfizer.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Guardant Health Triple: [Khosla Ventures, portfolioCompany, Guardant Health]
Generated description
Guardant Health is a precision oncology company specializing in blood-based liquid biopsy tests to detect, monitor, and guide treatment of cancer.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Guardant Health Target entity description: Guardant Health is a precision oncology company specializing in blood-based liquid biopsy tests to detect, monitor, and guide treatment of cancer.
-
A.
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals is a leading American biotechnology company known for developing innovative antibody-based therapies for serious diseases, including eye disorders, cancer, and inflammatory conditions.
-
B.
Ariad Pharmaceuticals
Ariad Pharmaceuticals was a biotechnology company focused on developing targeted therapies for cancer and other serious diseases.
-
C.
Seagen
Seagen is a biotechnology company specializing in the development of antibody-drug conjugate (ADC) therapies for cancer treatment.
-
D.
Genocea Biosciences
Genocea Biosciences is a biotechnology company that develops T cell–targeted vaccines and immunotherapies using a proprietary antigen discovery platform.
-
E.
BioNTech
BioNTech is a German biotechnology company best known for developing one of the first mRNA-based COVID-19 vaccines in partnership with Pfizer.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d8278834a08190b0f1784e58d7b99c |
completed | April 9, 2026, 10:26 p.m. |
| NER | Named-entity recognition | batch_69de61c76e8081909994b95b631100e9 |
completed | April 14, 2026, 3:48 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69fcf80f03a48190a5374fb6374255a8 |
completed | May 7, 2026, 8:37 p.m. |
| NEDg | Description generation | batch_69fd09b00dc48190bec9853e3dc78f26 |
completed | May 7, 2026, 9:52 p.m. |
| NED2 | Entity disambiguation (via description) | batch_69fd0a4c377c81909af76e8bd47e2f2a |
completed | May 7, 2026, 9:55 p.m. |
Created at: April 10, 2026, 1:02 a.m.